|
Primary Antibodies
BCAP31 Antibody
Background
BCAP31 Antibody.
Additional Names
BCAP31, DXS1357E, accessory protein BAP31, CDM, BAP31, 6C6-AG, B-cell receptor-associated protein 31
|
Description
Left: Western blot analysis of BCAP31 in human placenta lysate (RIPA buffer, 35μg total protein per lane) using BCAP31 antibody (1μg/mL).
|
Source
BCAP31 antibody was raised against a synthetic peptide near the C-terminus of BCAP31.
Purification
BCAP31 antibody was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Clonality / Clone
This is a polyclonal antibody.
Host
BCAP31 antibody was raised in goat.
Please use anti-goat secondary antibodies.
Application
Peptide ELISA: Antibody detection limit dilution 1/4,000. Western Blot: Approx 30kDa band observed in human placenta and brain lysate (predicted MW of 28kDa according to NP_005736). Recommended for use at 1-3μg/ml.
Tested Application
E, WB
Buffer
BCAP31 antibody is supplied as 0.1mg of purified antibody, 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Blocking Peptide
Cat. No. 45-019P - BCAP31 Peptide
Storage
Aliquot and store at -20°C. Minimize freezing and thawing.
Positive Control
- Cat. No. 1309 - Human Placenta Lysate
Species Reactivity
H
Protein Accession Number
NP_005736.3
Short Description
(CT) BCAP31 / BAP31
This product belongs to the following categories:
Related Products
Datasheet 08-02W
|
|
